
IDEX Corporation (NYSE:IEX – Free Report) – Equities research analysts at Zacks Research lowered their Q3 2026 EPS estimates for shares of IDEX in a report issued on Tuesday, August 25th. Zacks Research analyst Team now expects that the industrial products company will post earnings per share of $2.19 for the quarter, down from their prior forecast of $2.20. The consensus estimate for IDEX’s current full-year earnings is $8.82 per share. Zacks Research also issued estimates for IDEX’s Q2 2027 earnings at $2.34 EPS and Q2 2028 earnings at $2.45 EPS.
Several other analysts also recently issued reports on IEX. Robert W. Baird set a $257.00 price objective on IDEX in a research report on Thursday, April 30th. Royal Bank Of Canada lifted their price objective on IDEX from $261.00 to $280.00 and gave the stock an “outperform” rating in a research report on Thursday, July 30th. TD Cowen boosted their target price on shares of IDEX from $260.00 to $275.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Oppenheimer restated an “outperform” rating and issued a $265.00 target price on shares of IDEX in a report on Thursday, July 30th. Finally, Mizuho raised shares of IDEX from a “neutral” rating to an “outperform” rating and raised their price target for the stock from $210.00 to $280.00 in a research note on Tuesday, August 11th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, IDEX presently has an average rating of “Moderate Buy” and an average price target of $260.80.
IDEX Stock Performance
IDEX stock opened at $234.91 on Thursday. IDEX has a fifty-two week low of $158.19 and a fifty-two week high of $243.80. The company has a market capitalization of $17.32 billion, a price-to-earnings ratio of 33.80, a PEG ratio of 2.17 and a beta of 0.98. The stock has a fifty day moving average of $228.47 and a two-hundred day moving average of $213.48. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.15 and a current ratio of 3.05.
IDEX (NYSE:IEX – Get Free Report) last posted its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. The firm had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.IDEX’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.07 EPS. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Optiver Holding B.V. purchased a new position in shares of IDEX during the 1st quarter worth about $27,000. Quantbot Technologies LP purchased a new stake in IDEX in the second quarter valued at approximately $33,000. SJS Investment Consulting Inc. increased its position in IDEX by 104.1% during the first quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 76 shares during the last quarter. Laurel Wealth Advisors LLC acquired a new position in IDEX during the fourth quarter worth approximately $27,000. Finally, CYBER HORNET ETFs LLC purchased a new position in IDEX during the second quarter worth approximately $35,000. Institutional investors and hedge funds own 97.96% of the company’s stock.
Insiders Place Their Bets
In related news, CAO Lisa M. Anderson sold 385 shares of the stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer directly owned 4,327 shares in the company, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.50% of the company’s stock.
IDEX Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were paid a $0.73 dividend. This represents a $2.92 annualized dividend and a yield of 1.2%. The ex-dividend date was Monday, July 6th. IDEX’s dividend payout ratio is presently 42.01%.
IDEX News Summary
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
- Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
- Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
- Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
- Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
- Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement
IDEX Company Profile
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Articles
- Five stocks we like better than IDEX
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
